For weight management, NICE has appraised several licensed medicines that are available through NHS pathways or regulated private clinics: Semaglutide (Wegovy) NICE Technology Appraisal TA875 recommends semaglutide as an option for managing overweight and obesity in adults with a BMI of 35 kg/m or more (or 3034.9 kg/m in certain circumstances) alongside at least one weight-related comorbidity, when used within a specialist weight management service
These medications also come in self-injectable pens and varying dose strengths
Reddy's on April 28, 2026 [9] and Apotex on May 1, 2026 [10]) after the data exclusivity period expired on January 4, 2026
You may feel hungry faster and find cravings harder to ignore, potentially leading to weight regain
Backup plans: Extra doses, pharmacy contacts, and replacements If your prescription and insurance allow it, bring one extra dose and keep it in the original packaging with the prescription label